Impact of a VI-polysaccharide conjugate vaccine in preventing Typhoid Fever in an endemic setting, Lalitpur, Nepal
<p>Globally, an estimated 11 to 21 million cases of febrile illness and 117,000 to 161,000 deaths are attributed to typhoid fever each year. Typhoid fever is prevalent mainly in low-resource settings with poor water, and inadequate sanitation and hygiene facilities, with South Asia accounting...
Κύριος συγγραφέας: | Shakya, M |
---|---|
Άλλοι συγγραφείς: | Pollard, A |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2022
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
ανά: Maile T. Phillips, κ.ά.
Έκδοση: (2023-03-01) -
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
ανά: Sodiomon B. Sirima, κ.ά.
Έκδοση: (2021-07-01) -
Costs of typhoid vaccination for international travelers from the United States
ανά: Heesoo Joo, κ.ά.
Έκδοση: (2025-03-01) -
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
ανά: Nginache Nampota-Nkomba, κ.ά.
Έκδοση: (2024-12-01) -
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
ανά: Megan E Carey, κ.ά.
Έκδοση: (2023-09-01)